Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1996
05/17/1996CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues
05/17/1996CA2204510A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204380A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996CA2204362A1 Recombinant alternaria alternata allergens
05/17/1996CA2204276A1 H. pylori fermentation process
05/17/1996CA2204256A1 Peptides for anti-allergy treatment
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/15/1996EP0711565A1 Inhibiting growth of leukemic cells by targeting HER-2 protein
05/15/1996EP0711564A1 Cross-reactive influenza A immunization
05/15/1996EP0711563A1 Novel Borrelia vaccine
05/15/1996EP0711415A1 Immunoassay for detecting collagen or collagen fragments
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0711340A1 High yielding influenza viruses
05/15/1996EP0711310A1 Human antibodies against varicella-zoster virus
05/15/1996EP0711176A1 Stabilised immunoglobulin preparations and method for preparing same
05/15/1996EP0537168B1 Ctaa 28a32, the antigen recognized by mca 28a32
05/15/1996EP0496839B1 Vaccine against drugs of abuse
05/15/1996EP0463114B1 Assay for and treatment of autoimmune diseases
05/15/1996EP0438474B1 Production of antibodies from transgenic animals
05/15/1996EP0400076B1 A synthetic antigen evoking anti-hiv response
05/15/1996EP0335910B1 Intraoperative and endoscopic tumor detection and therapy
05/15/1996DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen
05/15/1996CN1122613A Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
05/15/1996CN1122576A Therapeutic strategies for immunoinfective cluster virus infections
05/15/1996CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment
05/14/1996US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
05/14/1996US5516895 Antibodies specific towards gp 48
05/14/1996US5516685 Isolation and characterization of a novel protease from Streptomyces lividans
05/14/1996US5516675 Separation of lactoperoxidase, secretory component and lactoferrin from milk or whey with a cation exchange resin
05/14/1996US5516672 Stabilized peroxidase compositions and antibody compositions
05/14/1996US5516658 DNA encoding cytokines that bind the cell surface receptor hek
05/14/1996US5516653 Genetic engineering
05/14/1996US5516640 Method of determination of pivka
05/14/1996US5516632 Synthetic peptides
05/14/1996US5516630 Incubating rna sample with a labeled hepatitis virus cdna sequence to hybridize, separating unbound cdna from sample and detecting remaining labeled cdna
05/14/1996CA1338324C Monoclonal antibody for the selective immunological determination of intact procollagen peptide (type iii) and procollagen (type iii) in body fluids
05/14/1996CA1338323C Retrovirus capable of causing aids, means and methods for detecting it in vitro
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013593A2 Soluble single chain t cell receptors
05/09/1996WO1996013592A2 Protein kinase npk-110
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013589A1 T cell epitopes of the major allergens from ambrosia artemisiifolia
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013576A1 Neisseria meningitidis culture medium for outer membrane protein complex fermentation
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013515A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof
05/09/1996WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
05/09/1996WO1996013275A1 Methods and products for enhancing immune responses
05/09/1996WO1996013271A1 Compositions and methods for human gastrointestinal health
05/09/1996WO1996013161A1 Creating an aerosolized formulation of insulin
05/09/1996CA2204037A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof
05/09/1996CA2203910A1 Novel protein kinase (npk-110)
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203762A1 Compositions and methods for human gastrointestinal health
05/09/1996CA2201703A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710724A2 Toxoplasma gondii antigens
05/08/1996EP0710720A1 Method for the production of monoclonal antibodies utilizing a germfree animal
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710294A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis
05/08/1996EP0710287A1 Homologously recombinant slow growing mycobacteria and uses therefor
05/08/1996EP0710278A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
05/08/1996EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0710121A1 Method for treating multiple sclerosis
05/08/1996EP0710120A1 Recombinant swinepox virus
05/08/1996EP0710119A1 $i(PASTEURELLA HAEMOLYTICA) SUBUNIT VACCINE CONTAINING CAPSULAR POLYSACCHARIDE AND MURAMYL DIPEPTIDE
05/08/1996EP0710118A1 Vaccine against gram-negative bacterial infections
05/08/1996EP0710117A1 Phosphazene polyelectrolytes as immunoadjuvants
05/08/1996EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
05/08/1996EP0423198B1 Antibodies specific towards hiv 1 gp 48
05/08/1996EP0368966B1 Novel non-reverting shigella live vaccines
05/08/1996EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
05/08/1996EP0328578B1 Antigen recognized by mca 16-88
05/08/1996CN1122139A Improved HCV diagnostic agents
05/08/1996CN1121959A Recombinant infectious non-segmented negative strand RNA virus
05/07/1996US5514794 Antibody-drug conjugates
05/07/1996US5514781 Use of azoles as virucidal agents in solutions of biologically active proteins
05/07/1996US5514776 Antiallergen
05/07/1996US5514774 Conotoxin peptides
05/07/1996US5514773 Parasiticides, anthelmintics
05/07/1996US5514676 Amino-benzoic acids and derivatives, and methods of use
05/07/1996US5514599 Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
05/07/1996US5514598 Prenatal detection of meconium
05/07/1996US5514559 Immunologically active conjugates and method for their preparation
05/07/1996US5514556 Measurement of il-2 production by t helper cells in response to recall antigens
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/07/1996US5514544 Dna sequences for genetic engineering
05/07/1996US5514542 Methods for propagating retrovirus for use in antibody assays
05/07/1996US5514539 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
05/07/1996US5514376 Cell culture of hepatitis A virus
05/07/1996US5514375 Flavivirus recombinant poxvirus vaccine
05/07/1996US5514363 Attaching perrhenate or pertechnetate to fab fragments, medical imaging and antitumor therapy
05/07/1996CA1338318C Composition for vaccines
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
1 ... 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 ... 1823